Clinical Trial Update: A Study of Darbepoetin Alfa in Anemic Subjects Not Receiving Chemotherapy Who Have Completed the 20010103 Study [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating darbepoetin alfa in cancer patients with anemia who are not receiving chemotherapy (NCT001151…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Cancer

Drugs mentioned

• darbepoetin alfa (darbepoetin alfa)

Snippet

Sponsor: Amgen | Conditions: Anemia, Cancer | Phase 3 | Status: COMPLETED